Protocol summary

Study aim
Comparison of nanocurcumin and chlorhexidine mouthwash effect on the level of gingival crevicular fluid prostaglandin E2 of fixed orthodontic patients
Design
A single blinded blocked randomized clinical trial on patients undergoing fixed orthodontic treatment in four groups (the group using mouthwash containing curcumin nanoparticles, the group using chlorhexidine mouthwash, the group using both nanocurcumin and chlorhexidine mouthwash at the same time, and the control group)
Settings and conduct
Orthodontics Department, Dental School, Golestan University of Medical Sciences
Participants/Inclusion and exclusion criteria
Inclusion criteria: Agreement to participation in the study,15 to 35 years old, Passed at least 2 mounts after fixed orthodontics treatment, Negative for hypersensitivity to Curcumin and/or chlorhexidine Exclusion criteria: The presence of any ulcer or intraoral infection, Severe gingival inflammation or periodontal pocket, Systemic disease, Pregnant and lactating mothers, Antibiotics usage in a month before the study, Fluoride therapy in the last 6 months, Tobacco usage, Corticosteroids and NSAIDs usage
Intervention groups
nanocurcumin and chlorhexidine mouthwash application
Main outcome variables
prostaglandin E2 level in gingival crevicular fluid

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20220223054108N2
Registration date: 2023-06-10, 1402/03/20
Registration timing: prospective

Last update: 2023-06-10, 1402/03/20
Update count: 0
Registration date
2023-06-10, 1402/03/20
Registrant information
Name
Aliakbar Naghavialhosseini
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 17 3262 7823
Email address
a.a.nagavi@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2023-06-20, 1402/03/30
Expected recruitment end date
2023-10-07, 1402/07/15
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation of nanocurcumin and chlorhexidine mouthwash effect on the prostaglandin E2 biomarker concentration in gingival crevicular fluid of fixed orthodontic patients
Public title
Effect of nanocurcumin and chlorhexidine mouthwash on level of prostaglandin E2
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria:
Agreement to participation in the study 15 to 35 years old Passed at least 2 mounts after fixed orthodontics treatment Negative for hypersensitivity to Curcumin and/or chlorhexidine
Exclusion criteria:
The presence of any ulcer or intraoral infection Severe gingival inflammation or periodontal pocket Systemic disease Pregnant and lactating mothers Antibiotics usage in a month before the study Fluoride therapy in the last 6 months Tobacco usage Corticosteroids and NSAIDs usage
Age
From 15 years old to 35 years old
Gender
Both
Phase
2-3
Groups that have been masked
  • Participant
  • Data analyser
Sample size
Target sample size: 88
Randomization (investigator's opinion)
Randomized
Randomization description
Eligible subjects will be assigned to the nanocurcumin and chlorhexidine mouthwash groups, the nanocurcumin only and chlorhexidine only, and the control group using the random block method. We first create a random sequence of 11 eight-block random blocks. Random numbers were generated in R software and In each block, each letter A, B, C, D is repeated twice. ABCDACDB, CADBACBD, DACBBCAD, ABBCDACD, CADBACDB,… In the desired sequence, there will be 22 letters from each letter A, B, C, D. According to the above block, 88 envelopes will be prepared, and in each envelope, the letters A, B, C, D will be placed and will be numbered from 1 to 88. The person delivering the envelopes to the patients does not know what is inside. This intervention is a two-sided blind type where the researcher knows the type of mouthwash, but the patients do not know about it. A random sequence is produced by a statistics and methodology consultant who does not have access to patients. Patients who received the letter A in the nanocurcumin mouthwash group, patients who received the letter B in the chlorhexidine group, and patients who received the letter C in the nanocurcumin and chlorhexidine group patients who received the letter D in the control group will be placed.
Blinding (investigator's opinion)
Double blinded
Blinding description
In this study, only the researcher knows the type of mouthwash prescribed for each patient. Nurses and patients do not have any information about the type of mouthwash to use and only receive instructions on how to use it. The random sequence generation is done by the statistics and methodology consultant, but he does not have access to the patients and is in the category of blinded subjects.
Placebo
Not used
Assignment
Factorial
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Research Ethics Committees of Golestan University of Medical Sciences
Street address
5th Shahryar
City
Gorgan
Province
Golestan
Postal code
4913983635
Approval date
2023-03-05, 1401/12/14
Ethics committee reference number
IR.GOUMS.REC.1402.001

Health conditions studied

1

Description of health condition studied
teeth shifting
ICD-10 code
Z51.8
ICD-10 code description
Encounter for other specified aftercare

Primary outcomes

1

Description
Prostaglandin E2 before and two weeks later in all studied groups
Timepoint
Measurement of prostaglandin E2 at the study's baseline (before starting treatment) and two weeks after consuming the prescribed mouthwashes for each group
Method of measurement
Enzyme-linked Immunosorbent Assay (ELISA test)

Secondary outcomes

1

Description
Patients' perception of taste in the group of patients using prescribed mouthwashes
Timepoint
The seventh day after using the prescribed mouthwashes
Method of measurement
Individually asking each of the participants about the taste of the prescribed mouthwash based on a questionnaire to check the quality of mouthwash.

Intervention groups

1

Description
Intervention group: In this group, patients are asked to mix 20 drops of nanocurcumin mouthwash with 10 cc of water and use for 30 seconds as a mouthwash twice a day for two weeks after brushing. Dr. Khori Danesh Bonyan Pharmaceutical Company makes Nanocurcumin mouthwash with a concentration of 2% with confirmation code No. 184620 of Golestan University of Medical Sciences. This mouthwash is prepared with the chemical composition C21H20O6 with over 70% purity degree and a molecular weight of 368 from Sigma & Aldrich Co.
Category
Prevention

2

Description
Intervention group: In this group, patients are asked to mix 20 drops of 0.2% chlorhexidine mouthwash with 10 cc of water and use for 30 seconds according to the written instruction on the mouthwash twice a day for two weeks after brushing.
Category
Prevention

3

Description
Intervention group: In this group, patients are asked to mix 20 drops of nanocurcumin plus chlorhexidine combined mouthwash with 10 cc of water and use for 30 seconds as a mouthwash twice a day for two weeks after brushing.
Category
Prevention

4

Description
Control group: In this group, patients are asked to use 10 cc of 0.9% normal saline as a mouthwash for 30 seconds as a mouthwash twice a day for two weeks after brushing.
Category
N/A

Recruitment centers

1

Recruitment center
Name of recruitment center
Orthodontics Department- Dental School- Golestan University of Medical Sciences
Full name of responsible person
Aliakbar Naghavialhosseini
Street address
Shahryar 5 St., Shahryar Town
City
Gorgan
Province
Golestan
Postal code
4913983635
Phone
+98 911 171 6706
Email
a.a.nagavi@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Gorgan University of Medical Sciences
Full name of responsible person
Dr. Narges Beigam Mirbehbahani
Street address
beginning of Shasat Kola Road
City
Gorgan
Province
Golestan
Postal code
49341-74515
Phone
+98 17 3245 1660
Email
mirbeh@goums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
No
Title of funding source
Gorgan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Gorgan University of Medical Sciences
Full name of responsible person
Aliakbar Naghavialhosseini
Position
Assistant professor
Latest degree
Specialist
Other areas of specialty/work
Dentistry
Street address
Shahryar 5 St., Shahryar Town
City
Gorgan
Province
Golestan
Postal code
4913983635
Phone
+98 17 3262 7823
Email
a.a.nagavi@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Gorgan University of Medical Sciences
Full name of responsible person
Aliakbar Naghavialhosseini
Position
Assistant professor
Latest degree
Specialist
Other areas of specialty/work
Dentistry
Street address
Shahryar 5 St., Shahryar Town
City
Gorgan
Province
Golestan
Postal code
4913983635
Phone
+98 17 3262 7823
Email
a.a.nagavi@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Gorgan University of Medical Sciences
Full name of responsible person
Aliakbar Naghavialhosseini
Position
Assistant professor
Latest degree
Specialist
Other areas of specialty/work
Dentistry
Street address
Shahryar 5 St., Shahryar Town
City
Gorgan
Province
Golestan
Postal code
4913983635
Phone
+98 17 3262 7823
Email
a.a.nagavi@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Not applicable
Data Dictionary
Not applicable
Loading...